The PAINCARE study is a substudy of the international STEPCARE trial, which investigates sedation, analgesia, and outcomes after cardiac arrest. The purpose of PAINCARE is to examine how pain, its assessment, and its treatment are related to delirium, resource use, and long-term outcomes in patients who have been resuscitated after cardiac arrest and treated in the intensive care unit (ICU). Pain is frequent in critically ill patients but often underrecognized and undertreated, particularly among those who are sedated or mechanically ventilated. After cardiac arrest, patients may experience pain caused by chest compressions, invasive procedures, or prolonged immobilization. Despite this, little is known about how pain is assessed and managed in this group or how pain and analgesic treatment influence clinical recovery and patient-reported outcomes. PAINCARE will collect detailed information on pain intensity, pain assessments, and analgesic use in parallel with data on sedation, delirium, and recovery. Data will be obtained through the same electronic case report form (eCRF) and procedures as the main STEPCARE trial. The main question PAINCARE aims to answer is: How are pain and pain management related to delirium, ICU resource use, and long-term outcomes in patients who have survived cardiac arrest? By improving understanding of pain and its management in this vulnerable patient group, the study seeks to inform better pain assessment and treatment strategies in the ICU, with the ultimate goal of improving comfort, reducing complications such as delirium, and supporting better recovery for survivors of cardiac arrest.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Restricted mean time (hours) in moderate/severe pain while alive and in ICU by 168 h
Timeframe: From enrollment to 168 hours